Butterfly Network Advances AI-Powered Ultrasound for Aortic Screening

Butterfly Network Inc. (NYSE:BFLY) is one of the most promising penny stocks under $5. On August 5, Butterfly Network announced advancements in AI-powered screening for aortic valve and aorta conditions. These developments include new research and the launch of a training tool called Butterfly ScanLab.

A study by Tufts Medical Center, published in the European Heart Journal – Imaging Methods and Practice, highlighted the potential of ML models to enable earlier detection of aortic stenosis/AS. The research showed that an ML model, when fine-tuned for use on Butterfly iQ+ handheld ultrasound devices, achieved an AUROC of 0.94 for differentiating between no aortic stenosis and any degree of the condition.

Butterfly Network Advances AI-Powered Ultrasound for Aortic Screening

A doctor looking at a ultrasound system with a Compass software interface, demonstrating the sophistication of the device.

Aortic stenosis, which is a narrowing of the aortic valve, affects over 13% of Americans aged 75 and older and is often undiagnosed until it becomes advanced. Undiagnosed cases are associated with a higher risk of procedures, worse outcomes, and increased healthcare costs.

Butterfly Network Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the US and internationally.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

This article is originally published at Insider Monkey.